Earnings Date
Oct 18
EPS
$1.140
Quarterly Revenue
$10.1B
Annual Revenue (as of Sep 30)
$40B
Earnings History
Analyze the earnings history of Abbott Laboratories using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/24/2024 | AM | ABT | Q4 | $1.03 | — | — | — | $10.09B | — | — | — | Get Alert |
| 10/18/2023 | AM | ABT | Q3 | $1.15 | $1.04 | $1.14 | 9.62% | $10.41B | $9.32B | $10.14B | 8.83% | Get Alert |
| 07/20/2023 | AM | ABT | Q2 | $1.43 | $1.05 | $1.08 | 2.86% | $11.26B | $9.70B | $9.98B | 2.87% | Get Alert |
| 04/19/2023 | AM | ABT | Q1 | $1.73 | $0.99 | $1.03 | 4.04% | $11.89B | $9.64B | $9.75B | 1.11% | Get Alert |
| 01/25/2023 | AM | ABT | Q4 | $1.32 | $0.92 | $1.03 | 11.96% | $11.47B | $9.64B | $10.09B | 4.68% | Get Alert |
| 10/19/2022 | AM | ABT | Q3 | $1.40 | $0.94 | $1.15 | 22.34% | $10.93B | $9.64B | $10.41B | 7.99% | Get Alert |
| 07/20/2022 | AM | ABT | Q2 | $1.17 | $1.12 | $1.43 | 27.68% | $10.22B | $10.29B | $11.26B | 9.40% | Get Alert |
| 04/20/2022 | AM | ABT | Q1 | $1.32 | $1.47 | $1.73 | 17.69% | $10.46B | $11.02B | $11.89B | 7.94% | Get Alert |
| 01/26/2022 | AM | ABT | Q4 | $1.45 | $1.21 | $1.32 | 9.09% | $10.70B | $10.71B | $11.47B | 7.08% | Get Alert |
| 10/20/2021 | AM | ABT | Q3 | $0.98 | $0.94 | $1.40 | 48.94% | $8.85B | $9.54B | $10.93B | 14.55% | Get Alert |
| 07/22/2021 | AM | ABT | Q2 | $0.57 | $1.02 | $1.17 | 14.71% | $7.33B | $9.69B | $10.22B | 5.50% | Get Alert |
| 04/20/2021 | AM | ABT | Q1 | $0.65 | $1.27 | $1.32 | 3.94% | $7.73B | $10.69B | $10.46B | -2.19% | Get Alert |
| 01/27/2021 | AM | ABT | Q4 | $0.95 | $1.35 | $1.45 | 7.41% | $8.31B | $9.94B | $10.70B | 7.66% | Get Alert |
| 10/21/2020 | AM | ABT | Q3 | $0.84 | $0.90 | $0.98 | 8.89% | $8.08B | $8.51B | $8.85B | 4.03% | Get Alert |
| 07/16/2020 | AM | ABT | Q2 | $0.82 | $0.41 | $0.57 | 39.02% | $7.98B | $6.75B | $7.33B | 8.56% | Get Alert |
| 04/16/2020 | AM | ABT | Q1 | $0.63 | $0.58 | $0.65 | 12.07% | $7.54B | $7.34B | $7.73B | 5.26% | Get Alert |
| 01/22/2020 | AM | ABT | Q4 | $0.81 | $0.95 | $0.95 | 0.00% | $7.76B | $8.26B | $8.31B | 0.65% | Get Alert |
| 10/16/2019 | AM | ABT | Q3 | $0.75 | $0.84 | $0.84 | 0.00% | $7.66B | $8.11B | $8.08B | -0.42% | Get Alert |
| 07/17/2019 | AM | ABT | Q2 | $0.73 | $0.80 | $0.82 | 2.50% | $7.77B | $8.00B | $7.98B | -0.26% | Get Alert |
When is Abbott Laboratories (NYSE:ABT) reporting earnings?
Abbott Laboratories (ABT) is scheduled to report earnings on January 24, 2024. The last reported earnings were for reported on October 18, 2023 for Q3.
What were the latest earnings per share (EPS) for Abbott Laboratories (NYSE:ABT)?
The Actual EPS was $1.14, which beat the estimate of $1.04.
What were Abbott Laboratories’s (NYSE:ABT) revenues?
The Actual Revenue was $10.1B, which beat the estimate of $9.3B.
Browse earnings estimates, EPS, and revenue on all stocks.